In our study, we have shown that despite IGF1R and IR being expressed in all breast cancer subtypes including TNBC, in silico analysis demonstrated that neither IGFR1 nor IR expression are associated with outcome in this subtype. The gene discussed is IGF1R; the disease is breast carcinoma.